Dealbook
"Commentary on deals and the dealmakers behind them." This is a continuously updated site providing legal and mergers & acquisitions news.
Author: Andrew Ross Sorkin edits Dealbook and is also writes a weekly Dealbook column at the New York Times.
Blawg Related Categories: Mergers & Acquisitions • Trials & Litigation • Legal News Publication
Recent Posts from Dealbook
-
Repsol Acknowledges Offers for YPF, None Certain
Repsol YPF, the Spanish oil company, told the S.E.C. that it had received a number of proposals for its Argentine assets, though none of them firm offers, after reports of a bid from CNPC of…
-
Merkin Claims Investors Knew About Madoff
J. Ezra Merkin, whose investors lost more than $2 billion in Bernard L. Madoff's Ponzi scheme, is asserting that his clients knew their money was being invested with Mr. Madoff.
-
F.D.I.C. Rules May Hinder Private Equity Bank Deals
The F.D.I.C. issued preliminary guidelines that analysts said could stymie further plans by private equity firms and hedge funds to purchase failed banks.
-
No 'Bernie in the Morning' for Howard Stern
A frequent guest on his show might nearly have escaped the sentencing with a recording, but she was arrested inside the courtroom.
-
Marshals Seize Madoff Penthouse
Federal marshals took possession of the $7 million Manhattan penthouse apartment of the convicted swindler Bernard L. Madoff, an action that has forced his wife Ruth to move.
-
Drumbeat of Defaults Gets Louder
Standard and Poor's, the credit ratings agency, said Thursday that junk bond defaults hit 9.2 percent last month, up from 8.1 percent in May and much higher than the 2 percent in June 2008.
-
Murdoch Says He's Committed to MySpace
News Corp.'s chairman, Rupert Murdoch, said in an interview with TheStreet.com that he remains committed to MySpace, the social networking site, and isn't interested in buying The New York Times Co.
-
From Madoff Feeder to Rothko Seller
J. Ezra Merkin lost billions of dollars of his clients' money to the Madoff scheme. But how has he done as an art investor?
-
Johnson & Johnson to Take Stake in Elan
Elan's shares soared Thursday after Johnson & Johnson said it would pay $1 billion to the Irish drug maker to gain access to Alzheimer's disease treatments.
-
Exelon Raises Hostile Bid for NRG
Exelon said Thursday it raised its bid for rival power producer NRG Energy to about $7.5 billion in stock, marking the latest twist in the months-long takeover feud.